Welcome, Guest. Please login or register.
July 12, 2024, 04:08:30 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 204
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 37
Total: 37


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Liver Cancer Risk Higher for People With Well-Treated Hep B Versus Hep C  (Read 7511 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
The risk of hepatocellular carcinoma (HCC, the most common form of liver cancer) is higher among those with well-treated hepatitis B virus (HBV) compared with those cured of hepatitis C virus (HCV). However, in a recent study, this difference was not seen among those with cirrhosis of the liver or those who were not well treated for either virus.

Publishing their findings in the Journal of Viral Hepatology, researchers analyzed data on 2,000 people with hep B who were treated with Baraclude (entecavir) and 733 people with hep C who were treated with interferon and ribavirin (the standard treatment at the time of the study) at one hospital between 2004 and 2011.



© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.